Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%):  [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"]

Harri Hemilä

doi:10.1002/14651858.CD008965.pub3

Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%): [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"]

Harri Hemilä

Department of Public Health

Research output: Contribution to journal › Article › Scientific

Abstract

Feedback to the following Cochrane review:
Jefferson T, et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children.
Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965
http://www.ncbi.nlm.nih.gov/pubmed/22258996

Original language	English
Journal	Cochrane database of systematic reviews
Issue number	CD008965
Pages (from-to)	271-272
Number of pages	2
ISSN	1469-493X
DOIs	https://doi.org/10.1002/14651858.CD008965.pub3
Publication status	Published - 2013
MoE publication type	B1 Journal article

Fields of Science

3111 Biomedicine
317 Pharmacy
Influenza
zinc lozenges
vitamin C
Oseltamivir
Tamiflu
Antiviral Agents

Access to Document

10.1002/14651858.CD008965.pub3

Hemila_2013_Oseltamivir_EffectAccepted author manuscript, 49.8 KB
2014_Hemila_Tamiflu_FeedbackFinal published version, 150 KB

http://hdl.handle.net/10138/42534

Cite this

@article{40fc6d66c374486da6ebccfc76bcf02e,

title = "Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%): [Feedback on Cochrane review {"}Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children{"}]",

abstract = "Feedback to the following Cochrane review: Jefferson T, et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965http://www.ncbi.nlm.nih.gov/pubmed/22258996 ",

keywords = "3111 Biomedicine, 317 Pharmacy, Influenza, zinc lozenges, vitamin C, Oseltamivir, Tamiflu, Antiviral Agents",

author = "Harri Hemil{\"a}",

year = "2013",

doi = "10.1002/14651858.CD008965.pub3",

language = "English",

pages = "271--272",

journal = "Cochrane database of systematic reviews",

issn = "1469-493X",

publisher = "Wiley",

number = "CD008965",

}

Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%): [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"]. / Hemilä, Harri.
In: Cochrane database of systematic reviews, No. CD008965, 2013, p. 271-272.

Research output: Contribution to journal › Article › Scientific

TY - JOUR

T1 - Oseltamivir (Tamiflu) shortens the duration of influenza-like illness by 13% (95% CI: 8% to 18%)

T2 - [Feedback on Cochrane review "Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children"]

AU - Hemilä, Harri

PY - 2013

Y1 - 2013

N2 - Feedback to the following Cochrane review: Jefferson T, et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965http://www.ncbi.nlm.nih.gov/pubmed/22258996

AB - Feedback to the following Cochrane review: Jefferson T, et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev. 2012 Jan 18;1:CD008965http://www.ncbi.nlm.nih.gov/pubmed/22258996

KW - 3111 Biomedicine

KW - 317 Pharmacy

KW - Influenza

KW - zinc lozenges

KW - vitamin C

KW - Oseltamivir

KW - Tamiflu

KW - Antiviral Agents

U2 - 10.1002/14651858.CD008965.pub3

DO - 10.1002/14651858.CD008965.pub3

M3 - Article

SN - 1469-493X

SP - 271

EP - 272

JO - Cochrane database of systematic reviews

JF - Cochrane database of systematic reviews

IS - CD008965

ER -